Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 161 of the 162 references it cites were found in a registry or an index.

Novel Multi-Ingredient Supplement Facilitates Weight Loss and Improves Body Composition in Overweight and Obese Individuals: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Open access

Abstract

Background: Despite the growing recognition of the obesity crisis, its rates continue to rise. The current first-line therapies, such as dietary changes, energy restriction, and physical activity, are typically met with poor adherence. Novel nutritional interventions can address the root causes of obesity, including mitochondrial dysfunction, and facilitate weight loss. Objective: The objective of this study was to investigate the effects of a multi-ingredient nutritional supplement designed to facilitate mitochondrial function and metabolic health outcomes over a 12 wk period. Methods: Fifty-five overweight and/or obese participants (age (mean ± SEM): 26 ± 1; body mass index (BMI) (kg/m2): 30.5 ± 0.6) completed this double-blind, placebo-controlled clinical trial. Participants were randomized to 12 wks of daily consumption of multi-ingredient supplement (MIS; n = 28; containing 50 mg forskolin, 500 mg green coffee bean extract, 500 mg green tea extract, 500 mg beet root extract, 400 mg α-lipoic acid, 200 IU vitamin E, and 200 mg CoQ10) or control placebo (PLA, n = 27; containing microcrystalline cellulose) matched in appearance. The co-primary outcomes were bodyweight and fat mass (kg) changes. The secondary outcomes included other body composition measures, plasma markers of obesity, fatty liver disease biomarkers, resting energy metabolism, blood pressure, physical performance, and quality of life. The post-intervention differences between MIS and PLA were examined via ANCOVA which was adjusted for the respective pre-intervention variables. Results: After adjustment for pre-intervention data, there was a significant difference in weight (p < 0.001) and fat mass (p < 0.001) post-intervention between the PLA and MIS treatment arms. Post-intervention weight and fat mass were significantly lower in MIS. Significant post-intervention differences corrected for baseline were found in markers of clinical biochemistry (AST, p = 0.017; ALT, p = 0.008), molecular metabolism (GDF15, p = 0.028), and extracellular vesicle-associated miRNA species miR-122 and miR-34a in MIS (p < 0.05). Conclusions: Following the 12 wks of MIS supplementation, weight and body composition significantly improved, concomitant with improvements in molecular markers of liver health and metabolism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu15173693

Cites

161 of 161 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Characterization of anthropometric changes following 12 wks of a multi-ingredient supplement (MIS, n = 28, green bars) compared to placebo (PLA, n = 27, pink bars). Post-intervention differences between treatment arms were compared using one-way ANCOVA, implementing the corresponding pre-intervention variables as covariates. Post-intervention data are presented as adjusted means ± SEs. Asterisks (*) denote significant (p < 0.05) between-group differences versus PLA, p ≥ 0.05, *; p ≤ 0.05, **; p ≤ 0.01, ***; p ≤ 0.001. Number signs (#) denote significant within-group differences relative to Day 0 (baseline), assessed via paired t-test, #; p ≤ 0.05, ##; p ≤ 0.01, ###; p ≤ 0.001. (A) Post-intervention weight (kg). (B) Individual change (Δ) in body weight (kg) following 12 wk intervention in the PLA and MIS group. (C) Post-intervention DXA-derived fat mass (kg). (D) Post-intervention DXA-derived fat-free mass (kg). (E) Post-intervention BMI (kg/m2). (F) Post-intervention waist-to-height ratio (a.u.). (G) Post-intervention DXA-derived regional body fat mass (kg). (H) Representative image of regional body fat mass demarcations.
Figure 1 Characterization of anthropometric changes following 12 wks of a multi-ingredient supplement (MIS, n = 28, green bars) compared to placebo (PLA, n = 27, pink bars). Post-intervention differences between treatment arms were compared using one-way ANCOVA, implementing the corresponding pre-intervention variables as covariates. Post-intervention data are presented as adjusted means ± SEs. Asterisks (*) denote significant (p < 0.05) between-group differences versus PLA, p ≥ 0.05, *; p ≤ 0.05, **; p ≤ 0.01, ***; p ≤ 0.001. Number signs (#) denote significant within-group differences relative to Day 0 (baseline), assessed via paired t-test, #; p ≤ 0.05, ##; p ≤ 0.01, ###; p ≤ 0.001. (A) Post-intervention weight (kg). (B) Individual change (Δ) in body weight (kg) following 12 wk intervention in the PLA and MIS group. (C) Post-intervention DXA-derived fat mass (kg). (D) Post-intervention DXA-derived fat-free mass (kg). (E) Post-intervention BMI (kg/m2). (F) Post-intervention waist-to-height ratio (a.u.). (G) Post-intervention DXA-derived regional body fat mass (kg). (H) Representative image of regional body fat mass demarcations.CC BY · PubMed Central
Figure 2 Characterization of plasma and circulating molecular signaling factors following 12 wks of a multi-ingredient supplement (MIS, green bars) compared to placebo (PLA, pink bars). (A) Post-intervention plasma GDF15 (pg/mL). Post-intervention differences between treatment arms were compared using one-way ANCOVA, implementing the corresponding pre-intervention variables as covariates. Within-group comparisons were made using a paired t-test. (B) Post-intervention plasma FGF21 (pg/mL). (C) Post-intervention plasma IL-6 (pg/mL). (D) Post-intervention plasma leptin (ng/mL). (E) Extracellular vesicle (EV)-associated miRNA species shown as fold change from Day 0 (baseline), n = 15 per group. miRNAs are normalized to exogenous miRNA, cel-miR-54 added prior to RNA isolation. Between-group comparisons were made using the Mann–Whitney U test. Within-group comparisons were made using the non-parametric sign rank test. Asterisks (*) denote significant (p < 0.05) between-group differences versus PLA, p ≥ 0.05, *; p < 0.05. Number signs (#) denote significant within-group differences relative to Day 0 (baseline), #; p < 0.05, ##; p ≤ 0.01. Post-intervention data are presented as adjusted means ± SEs. GDF15, Growth differentiation factor 15; FGF21, fibroblast growth factor 21; IL-6, interleukin 6; miRNA, microRNA.
Figure 2 Characterization of plasma and circulating molecular signaling factors following 12 wks of a multi-ingredient supplement (MIS, green bars) compared to placebo (PLA, pink bars). (A) Post-intervention plasma GDF15 (pg/mL). Post-intervention differences between treatment arms were compared using one-way ANCOVA, implementing the corresponding pre-intervention variables as covariates. Within-group comparisons were made using a paired t-test. (B) Post-intervention plasma FGF21 (pg/mL). (C) Post-intervention plasma IL-6 (pg/mL). (D) Post-intervention plasma leptin (ng/mL). (E) Extracellular vesicle (EV)-associated miRNA species shown as fold change from Day 0 (baseline), n = 15 per group. miRNAs are normalized to exogenous miRNA, cel-miR-54 added prior to RNA isolation. Between-group comparisons were made using the Mann–Whitney U test. Within-group comparisons were made using the non-parametric sign rank test. Asterisks (*) denote significant (p < 0.05) between-group differences versus PLA, p ≥ 0.05, *; p < 0.05. Number signs (#) denote significant within-group differences relative to Day 0 (baseline), #; p < 0.05, ##; p ≤ 0.01. Post-intervention data are presented as adjusted means ± SEs. GDF15, Growth differentiation factor 15; FGF21, fibroblast growth factor 21; IL-6, interleukin 6; miRNA, microRNA.CC BY · PubMed Central
Figure 3 Characterization of plasma antioxidant content and capacity following 12 wks of a multi-ingredient supplement (MIS, green bars) compared to placebo (PLA, pink bars). (A) Post-intervention plasma Trolox equivalents. Post-intervention variables were compared using one-way ANCOVA, with corresponding baseline variables as covariates. Within-group differences relative to Day 0 (baseline) were assessed via paired t-test (B) Post-intervention plasma CoQ10 content. Between-group comparisons were made using the Mann–Whitney U test. Within-group comparisons were made using the non-parametric sign rank test. Number signs (#) denote significant within-group differences relative to Day 0 (baseline), #; p < 0.05. Post-intervention data are presented as adjusted means ± SEs. CoQ10; coenzyme Q10.
Figure 3 Characterization of plasma antioxidant content and capacity following 12 wks of a multi-ingredient supplement (MIS, green bars) compared to placebo (PLA, pink bars). (A) Post-intervention plasma Trolox equivalents. Post-intervention variables were compared using one-way ANCOVA, with corresponding baseline variables as covariates. Within-group differences relative to Day 0 (baseline) were assessed via paired t-test (B) Post-intervention plasma CoQ10 content. Between-group comparisons were made using the Mann–Whitney U test. Within-group comparisons were made using the non-parametric sign rank test. Number signs (#) denote significant within-group differences relative to Day 0 (baseline), #; p < 0.05. Post-intervention data are presented as adjusted means ± SEs. CoQ10; coenzyme Q10.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 162 references

Cited by

See all 33

Metadata

Authors
Nederveen, J. P., Mastrolonardo, A. J., Xhuti, D., Di Carlo, A., Manta, K., Fuda, M. R., & Tarnopolsky, M. A.
Affiliations
  • McMaster University Medical Centre (CA)
  • Department of Pediatrics, Faculty of Health Sciences, McMaster University Medical Center (MUMC), Hamilton, ON L8N 3Z5, Canada
Corresponding author
Tarnopolsky, Mark A.
Venue
Nutrients
Publisher
MDPI AG
Published
2023-08-23
Volume
15
Issue
17
Pages
3693
ISSN
2072-6643 (ISSN-L)
OpenAlex
W4386121374
Cited by
33
References
162
Citations by year
2026: 7 · 2025: 19 · 2024: 6 · 2023: 1
FWCI
5.12
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • TSpace (University of Toronto) (submittedVersion, cc-by)
Funders
Canadian Institutes of Health Research (143325)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
  • Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
Keywords
obesity, weight loss, dietary supplements, mitochondrial function, metabolic health, body composition, fat mass, forskolin, green coffee bean extract, green tea extract, alpha-lipoic acid, coenzyme Q10, vitamin E, hepatic steatosis, extracellular vesicles, miR-122, miR-34a, GDF15
MeSH terms
Antioxidants, Body Composition, Humans, Obesity, Polyesters, Quality of Life, Dietary Supplements, MicroRNAs, Overweight

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Novel Multi-Ingredient Supplement Facilitates Weight Loss and Improves Body Composition in Overweight and Obese Individuals: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. https://app.cochat.ai/papers/10.3390/nu15173693
The paper
Nederveen, J. P., Mastrolonardo, A. J., Xhuti, D., Di Carlo, A., Manta, K., Fuda, M. R., & Tarnopolsky, M. A. (2023). Novel Multi-Ingredient Supplement Facilitates Weight Loss and Improves Body Composition in Overweight and Obese Individuals: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Nutrients. https://doi.org/10.3390/nu15173693

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.